Bentham Science Logo

Cardiovascular & Hematological Disorders-Drug Targets

Formerly: Current Drug Targets - Cardiovascular & Hematological Disorders

Volume 19, 3 Issues, 2019
ISSN: 2212-4063 (Online)
ISSN: 1871-529X (Print)
This journal supports open access

Articles Ahead of Print


CD123: A Novel Biomarker for Diagnosis and Treatment of Leukemia


Mingyue Shi, Ruijun Jeanna Su, Kamal-Preet Parmar, Rahman Chaudhry, Kai Sun, Jianyu Rao and Mingyi Chen*


DOI: 10.2174/1871529X19666190627100613
View Abstract View on PubMed



P Wave Dispersion and Silent Atrial Fibrillation in Cryptogenic Stroke: The Pathogenic Role of Inflammation


Maurizio Acampa*, Pietro Enea Lazzerini, Francesca Guideri, Rossana Tassi, Alessandra Cartocci and Giuseppe Martini


DOI: 10.2174/1871529X19666190410145501
View Abstract View on PubMed



An HHV-8 Positive HIV Negative Multicentric Castleman’s Disease, who Responded well to Rituximab Alone


Dimitris Kounatidis, Dimitra Rontogianni, Dimitrios Sampaziotis, Maria Vardaka, Chara Giatra, Christodoulos Dolapsakis, Evangelia Margellou and Natalia G. Vallianou*


DOI: 10.2174/1871529X19666190227185318
View Abstract View on PubMed



Impact of the Fontan Operation on Organ Systems


Miriam Michel*, Manuela Zlamy, Andreas Entenmann, Karin Pichler, Sabine Scholl-Bürgi, Daniela Karall, Ralf Geiger, Christina Salvador, Christian Niederwanger and Hideo Ohuchi


DOI: 10.2174/1871529X19666190211165124
View Abstract View on PubMed



Relationship Between Single-Nucleotide Polymorphisms of Tumor Necrosis Factor Alpha, Interleukin-10, Factor II and Factor V with Risk of Inhibitor Development in Patients with Severe Hemophilia A


Shahrzad Souri, Ghazaleh Dadashizadeh, Akbar Dorgalaleh, Shadi Tabibian, Mohammad Reza Keramati, Shaban Alizadeh, Maryam Sadat Hosseini, Farhad Zaker* and Mahmood Shams


DOI: 10.2174/1871529X19666190206152315
View Abstract View on PubMed


Genetics of Atrial Fibrilation: In Search of Novel Therapeutic Targets


Estefanía Lozano-Velasco, Carlos Garcia-Padilla, Amelia E. Aránega and Diego Franco*


DOI: 10.2174/1871529X19666190206150349
View Abstract View on PubMed


Carfilzomib: A Tale of a Heartbreaking Moment: Case Report and Concise Review of the Literature


W Serra*, A Fantin , C Longo , G Rabia , F De Rosa, C. Plenteda , F Re , E Crisafulli and A Chetta


DOI: 10.2174/1871529X19666181205100705
View Abstract View on PubMed


Protective Effects of Curcumin Against Nephrotoxic Agents


Tahereh Farkhondeh, Saeed Samarghandian*, Mohsen Azimi-Nezhad and Ali Mohammad Pourbagher Shahri


DOI: 10.2174/1871529X18666180905160830
View Abstract View on PubMed


Blood Biomarkers for the Differentiation of Cardiac Ischemic Stroke Subtypes: A Systematic Review


Surya Prakash Pandey, Prasoon Madhukar, Priya Dev, Deepika Joshi, Vijay Nath Mishra, Rameshwar Nath Chaurasia and Abhishek Pathak*


DOI: 10.2174/1871529X18666180829142354
View Abstract View on PubMed


Pure Red Cell Aplasia Caused by Azathioprine


Dimitris Kounatidis, Natalia Vallianou*, Vasiliki Daskalaki, Christos Masaoutis, Evangelia Margellou, Nikos Harhalakis and Evangelos Kokkinakis


DOI: 10.2174/1871529X18666180828145818
View Abstract View on PubMed




Editor-in-Chief

Garry X. Shen
University of Manitoba
Winnipeg, MB
Canada

Biography View Full Editorial Board

Journal History

Cardiovascular and Hematological Disorders-drug Targets was launched in 2001. Dr. Garry X. Shen serves as the Editor-in-Chief of the journal.
Track Your Manuscript:


New eBook

Frontiers in Clinical Drug Research-Hematology



You can view the contents of this eBook [here] or purchase it [here].

Related Journals

Related eBooks

eBooks Catalog